The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...
Impact and progress Frontiers' impact Progress Report 2022 All progress reports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback